Safety and Efficacy of OD-07656 and of Subsequent Vedolizumab Therapy in Moderately to Severely Active Ulcerative Colitis
Trial details
- Registry ID
- NCT06850727
- Drugs studied
- OD-07656, Vedolizumab
TrialRedline tracks 1 clinical trial sponsored by Odyssey Therapeutics: 1 Phase 2.
Company identity has not yet been verified
| Trial | Drugs studied | Status | Primary completion |
|---|---|---|---|
| Safety and Efficacy of OD-07656 and of Subsequent Vedolizumab Therapy in Moderately to Severely Active Ulcerative ColitisNCT06850727 | OD-07656, Vedolizumab | Recruiting | 2026-04Estimated |
Names as written in the registry records.
NCT06850727 · Odyssey Therapeutics
Before: Jan 2026. After: Apr 2026.